Browsing Category

24392 posts
Antigravity Updates A1 with Virtual Flight Simulator and Announces 15% Off US Sale

Antigravity Updates A1 with Virtual Flight Simulator and Announces 15% Off US Sale

The world’s first 8K 360 drone expands US retail availability to Amazon…

NYSE Content Advisory: Pre-Market update + Block Exceeds $200 Billion in Credit Provided to Its Users

NEW YORK, Jan. 27, 2026 /PRNewswire/ — The New York Stock Exchange…
Combatting the Energy Crisis: Eworld Showcases Low-Energy Glass Processing Machinery and Sustainable Solutions at Major Global Expos

Combatting the Energy Crisis: Eworld Showcases Low-Energy Glass Processing Machinery and Sustainable Solutions at Major Global Expos

International trade shows highlight Eworld’s energy-efficient glass processing technologies for architectural and…
Tineco Elevates Modern Living With a Smarter, More Balanced Floor Care Portfolio

Tineco Elevates Modern Living With a Smarter, More Balanced Floor Care Portfolio

SEATTLE, Jan. 27, 2026 /PRNewswire/ — As modern homes continue to evolve,…
Beetles Gel Polish Celebrates 5-Star Women's Basketball Recruit Jerzy Robinson's College Commitment

Beetles Gel Polish Celebrates 5-Star Women's Basketball Recruit Jerzy Robinson's College Commitment

Top ranked women’s basketball recruit Jerzy Robinson marks a defining life chapter through…
Home Control Signs Memorandum of Understanding with NTU Singapore to Explore AIoT Home Healthcare Ecosystem

Home Control Signs Memorandum of Understanding with NTU Singapore to Explore AIoT Home Healthcare Ecosystem

HONG KONG, Jan. 27, 2026 /PRNewswire/ — Home Control International Limited ("Home Control"…
AGCO Foundation Partners with the University of Sydney to Boost Resilience in Rural Communities

AGCO Foundation Partners with the University of Sydney to Boost Resilience in Rural Communities

The AU$150,000 partnership will create a dedicated agriculture program for the university.…
Skyhawk Therapeutics Announces Nine Month Interim Results in Patients from its Phase 1 Clinical Trial of SKY-0515 as a Treatment for Huntington's Disease

Skyhawk Therapeutics Announces Nine Month Interim Results in Patients from its Phase 1 Clinical Trial of SKY-0515 as a Treatment for Huntington's Disease

Nine-month findings show mean improvement in Composite Unified Huntington’s Disease Rating Scale…